Pharmacovigilance and Risk Management Strategies Conference

Mandarin Oriental Washington D.C.

New SIP Eases Investigators’ Burden

By Christine Pierre Found in: Article, Investigator Site, Clinical Research, Clinical Safety & Pharmacovigilance

In 2012, TransCelerate BioPharma Inc. was launched as a non-profit organization to improve the health of people around the world by…

DIA Webinar To Discuss How Technology and Collaboration Can Reinvent the Clinical Trial

Found in: Article, Clinical Research, Clinical Supplies, Clinical Safety & Pharmacovigilance, CMC

Many sponsor organizations are wrestling with how to improve the monitoring process with technology in an industry still fresh from the shackles of traditional paper-based data handling.

Advertising and Promotion Regulatory Affairs Conference

Omni Shoreham Hotel

Regulators Discuss BREXIT & Cancer Moonshot

Found in: Article, Regulatory Affairs, GMP, Public Policy / Law, Clinical Safety & Pharmacovigilance, Strategic Planning

One of the first DIA 2016 Annual Meeting DIAmond sessions, International Regulatory Convergence, Collaboration, and Cooperation…

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Westin Gaslamp Quarter, San Diego

Cost, Value, and Patient Outcomes: The Growing Need for Payer Engagement

By Gregory W. Daniel, PhD, MPH, RPh and Morgan H. Romine Found in: Pricing / Reimbursement, Public Policy / Law, Article, Clinical Supplies, Clinical Safety & Pharmacovigilance

Since passage of the Affordable Care Act in 2010, the last several years have seen a groundswell in physician payment and delivery reforms designed to achieve higher value health care through incentivizing higher quality care and lower overall costs.

Introduction to Signal Detection and Data Mining

DIA Global Center

Global Forum Special Section: Social Media @DIA

By Brandon King Found in: Article, Anti-doping, Academic Health Centers, Alternative / Herbal Med, Biotechnology, Clinical Data Management, CMC, Clinical Safety & Pharmacovigilance, Clinical Research, Clinical Supplies, Devices & Diagnostics, Medical Communications, Managed Health, Medical Writing

Social media is essentially like talking to someone, just through your respective computers, iPhones, smart devices or other electronic or digital tool.

Dalvir Gill

New SIP Eases Investigators’ Burden

By Christine Pierre Found in: Article, Investigator Site, Clinical Research, Clinical Safety & Pharmacovigilance

In 2012, TransCelerate BioPharma Inc. was launched as a non-profit organization to improve the health of people around the world by…

Regulators Discuss BREXIT & Cancer Moonshot

Found in: Article, Regulatory Affairs, GMP, Public Policy / Law, Clinical Safety & Pharmacovigilance, Strategic Planning

One of the first DIA 2016 Annual Meeting DIAmond sessions, International Regulatory Convergence, Collaboration, and Cooperation…

Cost, Value, and Patient Outcomes: The Growing Need for Payer Engagement

By Gregory W. Daniel, PhD, MPH, RPh and Morgan H. Romine Found in: Pricing / Reimbursement, Public Policy / Law, Article, Clinical Supplies, Clinical Safety & Pharmacovigilance

Since passage of the Affordable Care Act in 2010, the last several years have seen a groundswell in physician payment and delivery reforms designed to achieve higher value health care through incentivizing higher quality care and lower overall costs.

Global Forum Special Section: Social Media @DIA

By Brandon King Found in: Article, Anti-doping, Academic Health Centers, Alternative / Herbal Med, Biotechnology, Clinical Data Management, CMC, Clinical Safety & Pharmacovigilance, Clinical Research, Clinical Supplies, Devices & Diagnostics, Medical Communications, Managed Health, Medical Writing

Social media is essentially like talking to someone, just through your respective computers, iPhones, smart devices or other electronic or digital tool.

Global Forum Special Section: Orphan Drugs in the 21st Century

By Chris M. Slawecki Found in: Article, Clinical Safety & Pharmacovigilance, Clinical Research, Rare, Orphan Diseases

The US National Institutes of Health estimate that there are approximately 6,000 rare diseases affecting 25 million Americans. EURORDIS, the Voice of Rare Disease Patients in Europe, estimates the number of persons in Europe suffering from a rare disease at more than 30 million. Many of these conditions have no current treatment.

Pharmacovigilance and Risk Management Strategies Conference

Mandarin Oriental Washington D.C.

Advertising and Promotion Regulatory Affairs Conference

Omni Shoreham Hotel

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Westin Gaslamp Quarter, San Diego

Introduction to Signal Detection and Data Mining

DIA Global Center

DIA Statistics Forum

Bethesda North Marriott Hotel and Conference Center

Development of a Clinical Study Report

Clinical Statistics for Nonstatisticians

Sheraton Boston Hotel

New Drug Product Development and Life Cycle Management

Sheraton Boston Hotel

Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation

DIA Global Center

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Sheraton Philadelphia University City

Informed Consent

On demand

DIA Webinar To Discuss How Technology and Collaboration Can Reinvent the Clinical Trial

Found in: Article, Clinical Research, Clinical Supplies, Clinical Safety & Pharmacovigilance, CMC

Many sponsor organizations are wrestling with how to improve the monitoring process with technology in an industry still fresh from the shackles of traditional paper-based data handling.